| scholarly article | Q13442814 |
| P50 | author | Shengjun Xiao | Q64897411 |
| P2093 | author name string | Fan Yang | |
| Yang Yang | |||
| Zhen Wu | |||
| Chen Zhou | |||
| Xiaoling Zhang | |||
| Jingling Duan | |||
| Lihui Bian | |||
| Guowen Sheng | |||
| Shiang Lin | |||
| P2860 | cites work | Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation. | Q54109268 |
| The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling. | Q54112589 | ||
| Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer | Q56990996 | ||
| Phylogenetic comparison of Epstein-Barr virus genomes | Q59358045 | ||
| ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma | Q89220563 | ||
| Association of E-cadherin methylation with risk of nasopharyngeal cancer: A meta-analysis | Q89273955 | ||
| STAT3 as a therapeutic target in head and neck cancer | Q28299368 | ||
| Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches | Q29036707 | ||
| Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity | Q30452167 | ||
| Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands | Q33603682 | ||
| Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas | Q33689033 | ||
| Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA. | Q33907682 | ||
| Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway | Q34106993 | ||
| The significance of LMP1 expression in nasopharyngeal carcinoma | Q35008886 | ||
| Focus on nasopharyngeal carcinoma | Q35773862 | ||
| Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji Cells. | Q36473933 | ||
| Epstein-Barr virus latent membrane protein-1 effects on junctional plakoglobin and induction of a cadherin switch. | Q37408369 | ||
| LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells | Q37414197 | ||
| Nasopharyngeal carcinoma: a review | Q38376860 | ||
| The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma | Q38440804 | ||
| Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma | Q38480025 | ||
| Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers | Q38805572 | ||
| Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. | Q39123741 | ||
| Role of STAT3/5 and Bcl-2/xL in 2-methoxyestradiol-induced endoreduplication of nasopharyngeal carcinoma cells | Q39456688 | ||
| Latent membrane protein 1 mediates the resistance of nasopharyngeal carcinoma cells to TRAIL-induced apoptosis by activation of the PI3K/Akt signaling pathway | Q39488733 | ||
| STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. | Q39667478 | ||
| A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. | Q39736828 | ||
| Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization. | Q39749474 | ||
| Epstein-Barr virus facilitates the malignant potential of immortalized epithelial cells: from latent genome to viral production and maintenance | Q39765355 | ||
| Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. | Q40012174 | ||
| Epstein-Barr virus infection and nasopharyngeal carcinoma | Q40046633 | ||
| Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma | Q40078689 | ||
| Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells | Q40293195 | ||
| Multiple signal transducers and activators of transcription are induced by EBV LMP-1. | Q40551263 | ||
| Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling | Q40687983 | ||
| Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus | Q40934947 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 7377-7389 | |
| P577 | publication date | 2019-08-05 | |
| P1433 | published in | Cancer Management and Research | Q5031417 |
| P1476 | title | F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model | |
| P478 | volume | 11 |
| Q99629833 | Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis | cites work | P2860 |
Search more.